Eugene

[email protected]

LATEST

GSK To Buy Novartis’ Stake in Consumer Healthcare JV for $13 Billion
By

By
GlaxoSmithKline (GSK) has agreed to buy Novartis’ 36.5% stake in the companies’ consumer healthcare joint venture for $13 billion that would provide GSK full ownership of the business. The companies…

AGC Biologics To Add New Building Complex for HQ
By

By
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, plans to add a new building complex that will house the company’s global headquarters in Bothell. The new…

Abzena To Expand ADC Mfg Capabilities
By

By
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has completed a facility remodeling for a new antibody-drug conjugate (ADC) GMP manufacturing suite at its Bristol, Pennsylvania site. The…

Biocon Subsidiary Syngene Reports Expansion Plans
By

By
Syngene International, a Biocon subsidiary and Bangalore, India-headquartered contract research organization, has reported on its recent developments and expansion plans. In January 2018, Syngene signed a multi-year development and manufacturing…

Rephine Develops API Sourcing Portal
By

By
Rephine, a Stevenage, United Kingdom-headquartered provider of clinical and regulatory services to the pharmaceutical industry, has developed an active pharmaceutical ingredient (API) sourcing portal to streamline the API sourcing process…

Noramco, Ampac Fine Chemicals Form Strategic Alliance for Controlled Substances APIs
By

By
Noramco, a Wilmington, Delaware-headquartered producer of specialty active pharmaceutical ingredients (APIs), has partnered with Ampac Fine Chemicals (AFC), a Rancho Cordova, California-headquartered API manufacturer, to produce certain US Drug Enforcement…

PCI Pharma Services Expands Analytical Capabilities
By

By
PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, is investing in a laboratory expansion at its site in Tredegar, Wales, UK. The Tredegar facility is PCI’s center of…

Thermo Fisher Scientific To Build Pharma Services Facility
By

By
Thermo Fisher Scientific plans to invest $35 million in a pharmaceutical services supply-chain facility in Rheinfelden (Baden) Germany. The new facility will increase capacity for cold and ambient clinical trial…

DCAT Week ’18: CDMOs, CMOs, and Suppliers: Expansion Roundups
By

By
What have been the key developments from contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and other suppliers and companies supporting pharmaceutical /biopharmaceutical development and manufacturing thus far…

Hovione To Exit Generic Contrast Media Business
By

By
Hovione, a contract development and manufacturing organization, has sold all of the share capital of its generic contrast media business, iMAX Diagnostic Imaging. The sale marks the end of Hovione’s…